Former FDA chiefs slam Trump administration, label DOGE a disaster and warn of staff loss, while AstraZeneca announces AI partnership
Three former FDA commissioners publicly rebuked the Trump administration, saying its actions have harmed the agency.
They said the administration’s handling of a large staff departure stripped the FDA of institutional knowledge that will take years to rebuild.
The column notes that the administration also delayed a rule intended to allow patients to import prescription medicines from abroad, raising concerns about drug access.
In other news, AstraZeneca announced a new partnership focused on artificial intelligence, though details were limited in the source.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more”
read at STAT ↗
comments(0)
5-min edit window · permanent after that